129 related articles for article (PubMed ID: 11523053)
21. Genetic differences in endocrine pancreatic tumor subtypes detected by comparative genomic hybridization.
Speel EJ; Richter J; Moch H; Egenter C; Saremaslani P; Rütimann K; Zhao J; Barghorn A; Roth J; Heitz PU; Komminoth P
Am J Pathol; 1999 Dec; 155(6):1787-94. PubMed ID: 10595906
[TBL] [Abstract][Full Text] [Related]
22. Molecular study of a new family with hereditary renal cell carcinoma and a translocation t(3;8)(p13;q24.1).
Meléndez B; Rodríguez-Perales S; Martínez-Delgado B; Otero I; Robledo M; Martínez-Ramírez A; Ruiz-Llorente S; Urioste M; Cigudosa JC; Benítez J
Hum Genet; 2003 Feb; 112(2):178-85. PubMed ID: 12522559
[TBL] [Abstract][Full Text] [Related]
23. Pancreatic endocrine tumours: evidence for a tumour suppressor pathogenesis and for a tumour suppressor gene on chromosome 17p.
Beghelli S; Pelosi G; Zamboni G; Falconi M; Iacono C; Bordi C; Scarpa A
J Pathol; 1998 Sep; 186(1):41-50. PubMed ID: 9875139
[TBL] [Abstract][Full Text] [Related]
24. Loss of heterozygosity of 3p markers in neuroblastoma tumours implicate a tumour-suppressor locus distal to the FHIT gene.
Ejeskär K; Aburatani H; Abrahamsson J; Kogner P; Martinsson T
Br J Cancer; 1998 Jun; 77(11):1787-91. PubMed ID: 9667647
[TBL] [Abstract][Full Text] [Related]
25. [Allelic loss on chromosome 3p21-26 in nasopharyngeal carcinoma].
Deng L; Jiang N; Tan G
Zhonghua Zhong Liu Za Zhi; 1998 Jul; 20(4):248-50. PubMed ID: 10920974
[TBL] [Abstract][Full Text] [Related]
26. Unchanged frequency of loss of heterozygosity and size of the deleted region at 8p21-23 during metastasis of lung cancer.
Kurimoto F; Gemma A; Hosoya Y; Seike M; Takenaka K; Uematsu K; Yoshimura A; Shibuya M; Kudoh S
Int J Mol Med; 2001 Jul; 8(1):89-93. PubMed ID: 11408955
[TBL] [Abstract][Full Text] [Related]
27. Genomic alterations and instabilities in renal cell carcinomas and their relationship to tumor pathology.
Thrash-Bingham CA; Salazar H; Freed JJ; Greenberg RE; Tartof KD
Cancer Res; 1995 Dec; 55(24):6189-95. PubMed ID: 8521412
[TBL] [Abstract][Full Text] [Related]
28. Loss of heterozygosity on chromosomes 3, 9, 13, and 17, including the retinoblastoma locus, in uveal melanoma.
Scholes AG; Liloglou T; Maloney P; Hagan S; Nunn J; Hiscott P; Damato BE; Grierson I; Field JK
Invest Ophthalmol Vis Sci; 2001 Oct; 42(11):2472-7. PubMed ID: 11581185
[TBL] [Abstract][Full Text] [Related]
29. VHL and FHIT locus loss of heterozygosity is common in all renal cancer morphotypes but differs in pattern and prognostic significance.
Velickovic M; Delahunt B; Störkel S; Grebem SK
Cancer Res; 2001 Jun; 61(12):4815-9. PubMed ID: 11406557
[TBL] [Abstract][Full Text] [Related]
30. Molecular genetic investigation of sporadic renal cell carcinoma: analysis of allele loss on chromosomes 3p, 5q, 11p, 17 and 22.
Foster K; Crossey PA; Cairns P; Hetherington JW; Richards FM; Jones MH; Bentley E; Affara NA; Ferguson-Smith MA; Maher ER
Br J Cancer; 1994 Feb; 69(2):230-4. PubMed ID: 8297719
[TBL] [Abstract][Full Text] [Related]
31. Loss of heterozygosity at chromosome 3p in epithelial ovarian cancer in China.
Zhang GL; Xu KL
Int J Gynecol Cancer; 2002; 12(2):198-201. PubMed ID: 11975680
[TBL] [Abstract][Full Text] [Related]
32. Frequent loss of heterozygosity on chromosomes 3p and 17p without VHL or p53 mutations suggests involvement of unidentified tumor suppressor genes in follicular thyroid carcinoma.
Grebe SK; McIver B; Hay ID; Wu PS; Maciel LM; Drabkin HA; Goellner JR; Grant CS; Jenkins RB; Eberhardt NL
J Clin Endocrinol Metab; 1997 Nov; 82(11):3684-91. PubMed ID: 9360526
[TBL] [Abstract][Full Text] [Related]
33. Chromosome 8p alterations in sporadic and BRCA2 999del5 linked breast cancer.
Sigbjörnsdottir BI; Ragnarsson G; Agnarsson BA; Huiping C; Barkardottir RB; Egilsson V; Ingvarsson S
J Med Genet; 2000 May; 37(5):342-7. PubMed ID: 10807692
[TBL] [Abstract][Full Text] [Related]
34. Loss of heterozygosity at chromosome 3p correlates with telomerase activity in renal cell carcinoma.
Mehle C; Lindblom A; Ljungberg B; Stenling R; Roos G
Int J Oncol; 1998 Aug; 13(2):289-95. PubMed ID: 9664124
[TBL] [Abstract][Full Text] [Related]
35. Mutational analysis of PPARG as a candidate tumour suppressor gene in enteropancreatic endocrine tumours.
Costa-Guda J; Rosen ED; Jensen RT; Chung DC; Arnold A
Clin Endocrinol (Oxf); 2005 May; 62(5):603-6. PubMed ID: 15853832
[TBL] [Abstract][Full Text] [Related]
36. Sporadic and familial pheochromocytomas are associated with loss of at least two discrete intervals on chromosome 1p.
Benn DE; Dwight T; Richardson AL; Delbridge L; Bambach CP; Stowasser M; Gordon RD; Marsh DJ; Robinson BG
Cancer Res; 2000 Dec; 60(24):7048-51. PubMed ID: 11156410
[TBL] [Abstract][Full Text] [Related]
37. High resolution chromosome 3p allelotyping of human lung cancer and preneoplastic/preinvasive bronchial epithelium reveals multiple, discontinuous sites of 3p allele loss and three regions of frequent breakpoints.
Wistuba II; Behrens C; Virmani AK; Mele G; Milchgrub S; Girard L; Fondon JW; Garner HR; McKay B; Latif F; Lerman MI; Lam S; Gazdar AF; Minna JD
Cancer Res; 2000 Apr; 60(7):1949-60. PubMed ID: 10766185
[TBL] [Abstract][Full Text] [Related]
38. Molecular genetic analysis of the von Hippel-Lindau disease (VHL) tumour suppressor gene in gonadal tumours.
Foster K; Osborne RJ; Huddart RA; Affara NA; Ferguson-Smith MA; Maher ER
Eur J Cancer; 1995 Dec; 31A(13-14):2392-5. PubMed ID: 8652274
[TBL] [Abstract][Full Text] [Related]
39. Reconsideration of biallelic inactivation of the VHL tumour suppressor gene in hemangioblastomas of the central nervous system.
Gläsker S; Bender BU; Apel TW; van Velthoven V; Mulligan LM; Zentner J; Neumann HP
J Neurol Neurosurg Psychiatry; 2001 May; 70(5):644-8. PubMed ID: 11309459
[TBL] [Abstract][Full Text] [Related]
40. Von Hippel-Lindau tumour suppressor gene is not involved in sporadic human breast cancer.
Sourvinos G; Miyakis S; Liloglou TL; Field JK; Spandidos DA
Tumour Biol; 2001; 22(3):131-6. PubMed ID: 11275790
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]